Women in Biotech

Thursday 24 September 2020

Following a successful first event last year, our Women in Biotech series returns to Cambridge this September. Join us for an excellent evening of networking, drinks, and thought-provoking discussion at the University Arms in Cambridge.



18.15   Registration and networking

18.40   Welcome from BIA and Bird & Bird
Jane Wall, Director of Business Development and Membership Services, BIA
               Tbc, Bird & Bird 

18.50  Discussion and Q&A
Jane Osbourn OBE, Chair, Mogrify
               Anne Osbourn OBE, Project Leader, John Innes Centre

19.30  Networking and drinks
21:00  Close


University Arms
Parker's Tavern
Regent Street
Cambridge CB2 1AD    


Situated in the heart of Cambridge, University Arms is just a short walk or taxi/bus ride from Cambridge train station. It is also easily reached with other Cambridge bus routes or by taxi. 

There are park and ride services around Cambridge, or alternatively a few public car parks within easy walking distance of the venue including: Queen Anne Terrace car park and Grand Arcade car park.


Costs and T&Cs

BIA members - £30 +VAT
Non-members - £40 +VAT

Reduced rate - £25 +VAT*

By registering to this event you accept our Terms & Conditions

If you have any questions or problems registering, please contact biaevents@bioindustry.org 

* Available for Charity/NFP, at discretion of BIA. Please email BIAevents@bioindustry.org to receive this rate.


Dr Jane Osbourn OBE

Chair, Mogrify

CSO, Alchemab

Jane has over 30 years of experience in biologics discovery and development. Most recently, she was Vice President for R&D and Site Leader at MedImmune (AstraZeneca), formerly Cambridge Antibody Technology (CAT), where she contributed to the development of phage display technology.

Jane is a scientific leader in the field of antibody engineering, and has made a significant contribution to the discovery and development of 8 marketed drugs and over 40 clinical candidates. Jane is passionate about science education and the development of the UK biotech sector and has served as Chair of the Board of Directors of the BioIndustry Association for the past four years. She is currently a Director of Babraham Bioscience Technologies, and also a Director of Cambridge Enterprise. She was awarded Scrip’s Lifetime Achievement Award and an OBE in 2019 for services to drug discovery, development and biotechnology.

Anne Osbourn OBE

Project Leader

John Innes Centre

Anne Osbourn is a Project Leader at the John Innes Centre and Director of the Norwich Research Park Industrial Biotechnology Alliance. She is also an honorary professor at the University of East Anglia. Her research focuses on plant-derived natural products - function, synthesis, mechanisms of metabolic diversification and metabolic engineering. An important advance from the Osbourn laboratory has been the discovery that in plant genomes the genes needed to make particular natural products are often organised in clusters like ‘beads on a string’, a finding that has greatly accelerated our ability to find new pathways and chemistries of potential importance for the development of drugs and other useful compounds. She has established a synthetic biology platform based on transient plant expression that provides rapid access to previously inaccessible natural products and analogs at gram scale. Together these two step changes open up new routes to combine genomics and synthetic biology to synthesize and access previously inaccessible natural products and analogs for medicinal, agricultural and industrial applications. Anne has also developed and co-ordinates the Science, Art and Writing (SAW) Initiative, a cross-curricular science education outreach programme (www.sawtrust.org).

The BIA’s Women in Biotech event series has been running for over 12 years and aims to connect, inspire, and support women across the sector.


Thank you to our Women in Biotech series sponsor




BIA Annual Supporters